SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-19-013273
Filing Date
2019-08-22
Accepted
2019-08-22 16:28:19
Documents
8
Period of Report
2019-08-22
Effectiveness Date
2019-08-22

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 801797
2 def14a_001.jpg GRAPHIC 5917
3 def14a_002.jpg GRAPHIC 2119
4 def14a_003.jpg GRAPHIC 3506
5 proxy_001.jpg GRAPHIC 144792
6 proxy_002.jpg GRAPHIC 129095
7 proxy_003.jpg GRAPHIC 182511
8 proxy_004.jpg GRAPHIC 167808
  Complete submission text file 0001493152-19-013273.txt   1679361
Mailing Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 412-224-6100
Interpace Diagnostics Group, Inc. (Filer) CIK: 0001054102 (see all company filings)

IRS No.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24249 | Film No.: 191046372
SIC: 3841 Surgical & Medical Instruments & Apparatus